Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Risk Stratification in Covid-19

NCT04555187 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT04555187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04555187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Risk Stratification in Covid-19
Lead sponsor
Oregon Health and Science University
Phase
Observational
Overall status
Completed
Start date
June 8, 2020
Completion date
December 1, 2021
Enrollment
1,355 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular risk factor, covid19